Connecting Capabilities in Advanced Therapies
Led by King’s College London
HEI partners: University College London, Imperial College London, Queen Mary University of London, University of Bristol, The University of Manchester, Newcastle University, University of Cardiff, University of Birmingham, University of Edinburgh, University of Glasgow, Queen's University Belfast
CCF follow on funding award: £1,320,000
Advanced therapies include a variety of novel gene- and cell-based techniques, which can be used to treat a wide range of serious conditions. Funded through a Research England Connecting Capabilities Fund award, London Advanced Therapies was established in 2018. Since then, the programme has delivered an accessible and comprehensive package of activities that connects knowledge transfer across universities and encourages industry to benefit from London’s expertise in this field, which is a key growth area for life sciences in the UK and worldwide. Among the forms of knowledge exchange that LAT supports, for example, is the mapping of expertise – within hours of an approach from one of the many life sciences companies worldwide working in advanced therapies, they can be put in touch with relevant experts.
The additional funding will support the establishment of a nation-wide collaboration, UK Advanced Therapies (UKAT), creating a bridge between a successful London-focused endeavour and a UK wide, comprehensive network. Working together across the regions and nations we will maximise our capacity to attract inwards investment, making our capabilities readily accessible, and translating them into a competitive advantage to industry, thus further enhancing the UK's position as global leader in this field.